Altimmune to host virtual r&d day on march 13, 2025

Program to feature presentations from renowned kols in obesity, mash and two additional indications for pemvidutide following recent ind clearances by fda program to feature presentations from renowned kols in obesity, mash and two additional indications for pemvidutide following recent ind clearances by fda
ALT Ratings Summary
ALT Quant Ranking